Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6960730 | 0.82 | TP53 (0.48) | TP53CALM1TSHRALDH1A1TDP1 | |
| SCHEMBL16298659 | 0.78 | TP53 (0.43) | TP53CALM1TSHRALDH1A1IDO1 | |
| SCHEMBL8575145 | 0.78 | TP53 (0.50) | TP53CALM1TSHRALDH1A1TDP1 | |
| SCHEMBL8992235 | 0.76 | TP53 (0.42) | TP53CALM1TSHRALDH1A1TDP1 | |
| SCHEMBL41195 | 0.75 | CALM1 (0.50) | TP53CALM1TSHRALDH1A1TDP1 | |
| SCHEMBL9075638 | 0.72 | TP53 (0.50) | TP53CALM1TSHRALDH1A1TDP1 | |
| SCHEMBL476137 | 0.72 | ALDH1A1 (0.48) | TP53ALDH1A1TDP1LOXL2MAOB | |
| SCHEMBL703317 | 0.71 | CALM1 (0.45) | TP53CALM1TSHRALDH1A1TDP1 | |
| SCHEMBL703494 | 0.71 | CALM1 (0.45) | TP53CALM1TSHRALDH1A1TDP1 | |
| SCHEMBL8865473 | 0.70 | TAAR1 (0.44) | TP53CALM1TSHRTRPA1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 394 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119490523-A | Quaternary carbon chiral allylgem-silicon boron compound, synthesis method thereof and application thereof in allylboration reaction | 四川大学 | 2025-02-21 | — | — | CN | claimed |
| WO-2023161688-A1 | SILA-ANALOGUES OF VITAMIN D COMPOUNDS, METHOD OF PRODUCING SAID COMPOUNDS AND USES THEREOF | REQUIMTE - REDE DE QUÍMICA E TECNOLOGIA (PT) | 2023-08-31 | — | — | WO | claimed |
| CN-114206334-A | Process for preparing aminopyrimidine compounds | 艾库斯生物科学有限公司 | 2022-03-18 | — | — | CN | claimed |
| WO-2020247789-A1 | PROCESSES FOR PREPARING AMINOPYRIMIDINE COMPOUNDS | ARCUS BIOSCIENCES, INC. (US) | 2020-12-10 | — | — | WO | claimed |
| CN-106748690-A | A kind of iron catalysis oxidation alkene synthesizes the method for ketone | 南京师范大学 | 2017-05-31 | — | — | CN | claimed |
| EP-2267046-B1 | Process for homo- or copolymerization of conjugated olefines | STYRON EUROPE GMBH (CH) | 2013-08-07 | — | — | EP | claimed |
| US-20110213168-A1 | DEUTERATED VITAMIN D COMPOUNDS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2011-09-01 | — | — | US | claimed |
| EP-2360154-A1 | DEUTERATED VITAMIN D COMPOUNDS | Universidade De Santiago De Compostela (ES) | 2011-08-24 | — | — | EP | claimed |
| EP-2267046-A1 | Process for homo- or copolymerization of conjugated olefines | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-12-29 | — | — | EP | claimed |
| US-20100248947-A1 | PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-09-30 | — | — | US | claimed |
| EP-0817774-A1 | CYCLOHEXYLAMINO AND CYCLOHEXYLALKOXY NITROGEN HETEROCYCLES, METHODS OF PREPARING THEM AND THEIR USE AS PEST-CONTROL AGENTS AND FUNGICIDES | Hoechst Schering AgrEvo GmbH (DE) | 1998-01-14 | — | — | EP | claimed |
| EP-0793497-A1 | NOVEL ENEDIYNE QUINONE IMINES AND METHODS OF PREPARATION AND USE THEREOF | Sloan-Kettering Institute For Cancer Research (US) | 1997-09-10 | — | — | EP | claimed |
| WO-1996030345-A1 | CYCLOHEXYLAMINO AND CYCLOHEXYLALKOXY NITROGEN HETEROCYCLES, METHODS OF PREPARING THEM AND THEIR USE AS PEST-CONTROL AGENTS AND FUNGICIDES | HOECHST SCHERING AGREVO GMBH (DE) | 1996-10-03 | — | — | WO | claimed |
| WO-1996016655-A1 | NOVEL ENEDIYNE QUINONE IMINES AND METHODS OF PREPARATION AND USE THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-06-06 | — | — | WO | claimed |
| US-5516871-A | Diphenylsiloxane oligomers functionalized at both terminals and methods for the preparation thereof | DOW CORNING ASIA, LTD. (JP) | 1996-05-14 | — | — | US | claimed |
| US-5502229-A | ENDCAPPING | DOW CORNING ASIA, LTD. (JP) | 1996-03-26 | — | — | US | claimed |
| EP-0291787-B1 | Novel substituted silyl alkylene amines | MERRELL DOW PHARMA (US) | 1994-03-16 | — | — | EP | claimed |
| US-5164525-A | SYNTHETIC PROCESS FOR FK-506 TYPE MACROLIDE INTERMEDIATES | MERCK & CO., INC. (US) | 1992-11-17 | — | — | US | claimed |
| EP-0405994-A2 | Synthetic process for FK-506 type macrolide intermediates | MERCK & CO. INC. (US) | 1991-01-02 | — | — | EP | claimed |
| EP-0291787-A1 | Novel substituted silyl alkylene amines | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-11-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110213168-A1 | DEUTERATED VITAMIN D COMPOUNDS | CYP24A1, VDR, CYP2R1 | PTGS1 2892/4885PTGS2 3741/4885TP53 4009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.